Back to News
Jan 14, 2026 8:00 AM

What's Going On With BriaCell Therapeutics Stock Wednesday?

BriaCell Therapeutics Corp. (NASDAQ:BCTX) stock plunged on Wednesday after rallying on Tuesday on positive data from a breast cancer trial.

This small biotechnology company, focused on cancer, has a market capitalization of approximately $20.57 million, according to data from Benzinga Pro.

Capital Raise

During after-hours trading on Tuesday, BriaCell Therapeutics priced its public offering of $30 million.

The clinical-stage biotechnology company focused on cancer immunotherapies priced 5.37 million units at $5.59 per unit.

Each unit consists of one common share (or pre-funded warrant (“Pre-Funded Warrant”) in lieu thereof) and one ...